{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:06:58Z","timestamp":1773810418912,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.prp.2023.154431","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:15:27Z","timestamp":1680520527000},"page":"154431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Clinical significance and diagnostic value of QPCT, SCEL and TNFRSF12A in papillary thyroid cancer"],"prefix":"10.1016","volume":"245","author":[{"given":"Tairong","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuqian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengzhong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peishan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongdong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"73","key":"10.1016\/j.prp.2023.154431_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2023.154431_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.738213","article-title":"Burden of thyroid cancer from 1990 to 2019 and projections of incidence and mortality until 2039 in China: findings from global burden of disease study","volume":"12","author":"Cheng","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2023.154431_bib3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00292-019-00699-2","article-title":"[Individualization of the surgical procedure in response to overdiagnosis and overtreatment in differentiated thyroid carcinomas]","volume":"40","author":"Staubitz","year":"2019","journal-title":"Pathologe"},{"key":"10.1016\/j.prp.2023.154431_bib4","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1158\/0008-5472.CAN-08-0293","article-title":"RET\/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose","volume":"68","author":"Hamatani","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2023.154431_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41574-020-00414-9","article-title":"Understanding the ever-changing incidence of thyroid cancer","volume":"16","author":"Kitahara","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.prp.2023.154431_bib6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s00268-012-1423-5","article-title":"Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up","volume":"36","author":"Ito","year":"2012","journal-title":"World J. Surg."},{"key":"10.1016\/j.prp.2023.154431_bib7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamaoncol.2019.6851","article-title":"Incidence and mortality risk spectrum across aggressive variants of papillary thyroid carcinoma","volume":"6","author":"Ho","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.prp.2023.154431_bib8","article-title":"Predictive factor of large-volume central lymph node metastasis in clinical N0 papillary thyroid carcinoma patients underwent total thyroidectomy","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2023.154431_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/bjs.11430","article-title":"Recurrence following hemithyroidectomy in patients with low- and intermediate-risk papillary thyroid carcinoma","volume":"107","author":"Ahn","year":"2020","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.prp.2023.154431_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/dc.10043","article-title":"Diagnosis of \"follicular neoplasm\": a gray zone in thyroid fine-needle aspiration cytology","volume":"26","author":"Baloch","year":"2002","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.prp.2023.154431_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040775","article-title":"Molecular signature of indeterminate thyroid lesions: current methods to improve fine needle aspiration cytology (FNAC) diagnosis","volume":"18","author":"Cantara","year":"2017","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154431_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215567","article-title":"Papillary thyroid cancer prognosis: an evolving field","volume":"13","author":"Ulisse","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2023.154431_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.895428","article-title":"Construction of a Tumor Immune Microenvironment-Related Prognostic Model in BRAF-Mutated Papillary Thyroid Cancer","volume":"13","author":"Xia","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.prp.2023.154431_bib14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/er.2007-0007","article-title":"BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications","volume":"28","author":"Xing","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.prp.2023.154431_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.lungcan.2022.05.014","article-title":"Targeting BRAF-mutant non-small cell lung cancer: Current status and future directions","volume":"169","author":"Riudavets","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prp.2023.154431_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221105022","article-title":"Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR\/BRAF inhibitors","volume":"14","author":"Xu","year":"2022","journal-title":"Ther. Adv. Med Oncol."},{"key":"10.1016\/j.prp.2023.154431_bib17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s11864-022-00946-4","article-title":"Targeted Therapy for Melanomas Without BRAF V600 Mutations","volume":"23","author":"Menzer","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.prp.2023.154431_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.884428","article-title":"Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation","volume":"13","author":"Han","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"19","key":"10.1016\/j.prp.2023.154431_bib19","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S1470-2045(16)30166-8","article-title":"Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial","volume":"17","author":"Brose MS","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2023.154431_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6562149","article-title":"The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese Population","volume":"2022","author":"Ye","year":"2022","journal-title":"Int J. Endocrinol."},{"key":"10.1016\/j.prp.2023.154431_bib21","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ejso.2016.11.003","article-title":"BRAF(V600E) mutation as a predictor of thyroid malignancy in indeterminate nodules: A systematic review and meta-analysis","volume":"43","author":"Jinih","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.prp.2023.154431_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/dc.23302","article-title":", Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma","volume":"43","author":"Zhao","year":"2015","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.prp.2023.154431_bib23","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154431_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12672-016-0256-3","article-title":"TERT Promoter Mutations in Thyroid Cancer","volume":"7","author":"Alzahrani","year":"2016","journal-title":"Horm. Cancer"},{"issue":"29","key":"10.1016\/j.prp.2023.154431_bib25","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/carcin\/bgm094","article-title":"The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells","volume":"28","author":"Aguilera O","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.prp.2023.154431_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10585-019-10011-4","article-title":"A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence","volume":"37","author":"He","year":"2020","journal-title":"Clin. Exp. Metastas-.-."},{"key":"10.1016\/j.prp.2023.154431_bib27","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.7150\/ijms.63402","article-title":"Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer","volume":"18","author":"Liu","year":"2021","journal-title":"Int J. Med Sci."},{"key":"10.1016\/j.prp.2023.154431_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234566","article-title":"Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis","volume":"15","author":"Subhi","year":"2020","journal-title":"PLoS One"},{"issue":"64","key":"10.1016\/j.prp.2023.154431_bib29","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1158\/0008-5472.CAN-04-3078","article-title":"Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications","volume":"65","author":"Jarzab B","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2023.154431_bib30","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1038\/bjc.2013.574","article-title":"Iodine-131 dose-dependent gene expression: alterations in both normal and tumour thyroid tissues of post-Chernobyl thyroid cancers","volume":"109","author":"Abend","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2023.154431_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40659-018-0188-1","article-title":"Identification of key genes and miRNAs markers of papillary thyroid cancer","volume":"51","author":"Qiu","year":"2018","journal-title":"Biol. Res"},{"key":"10.1016\/j.prp.2023.154431_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.prp.2023.154431_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.advms.2016.06.003","article-title":"A comparative study of nuclear 8-hydroxyguanosine expression in Autoimmune Thyroid Diseases and Papillary Thyroid Carcinoma and its relationship with p53, Bcl-2 and Ki-67 cancer related proteins","volume":"62","author":"Mseddi","year":"2017","journal-title":"Adv. Med Sci."},{"key":"10.1016\/j.prp.2023.154431_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2023.154431_bib35","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4158\/EP14466.DSCR","article-title":"A.E.S.S. Committee, American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: The Increasing Incidence of Thyroid Cancer","volume":"21","author":"Davies","year":"2015","journal-title":"Endocr. Pr."},{"issue":"9","key":"10.1016\/j.prp.2023.154431_bib36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/thy.1998.8.751","article-title":"Cancer risk in individuals with benign thyroid disorders","volume":"8","author":"Mellemgaard A","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2023.154431_bib37","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1210\/jc.2017-02599","article-title":"Benign Thyroid Diseases and Risk of Thyroid Cancer: A Nationwide Cohort Study","volume":"103","author":"Kitahara","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2023.154431_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3803\/EnM.2020.35.2.443","article-title":"Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment","volume":"35","author":"Sulaieva","year":"2020","journal-title":"Endocrinol. Metab. (Seoul. )"},{"key":"10.1016\/j.prp.2023.154431_bib39","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s12253-019-00580-w","article-title":"Thyroid Carcinoma Coexisting with Hashimoto's Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis","volume":"25","author":"Molnar","year":"2019","journal-title":"Pathol. Oncol. Res"},{"key":"10.1016\/j.prp.2023.154431_bib40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/dc.21423","article-title":"FN1, GALE, MET, and QPCT overexpression in papillary thyroid carcinoma: molecular analysis using frozen tissue and routine fine-needle aspiration biopsy samples","volume":"39","author":"da Silveira Mitteldorf","year":"2011","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.prp.2023.154431_bib41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ebiom.2019.01.003","article-title":"Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma","volume":"40","author":"Cheng","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.prp.2023.154431_bib42","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1158\/0008-5472.CAN-06-1274","article-title":"Epigenetic silencing of novel tumor suppressors in malignant melanoma","volume":"66","author":"Muthusamy","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2023.154431_bib43","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.7150\/thno.35572","article-title":"DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma","volume":"9","author":"Zhao","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2023.154431_bib44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/ERC-12-0053","article-title":"Role of glutaminyl cyclases in thyroid carcinomas","volume":"20","author":"Kehlen","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.prp.2023.154431_bib45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5483\/BMBRep.2017.50.9.108","article-title":"Functional roles of CTCF in breast cancer","volume":"50","author":"Oh","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.prp.2023.154431_bib46","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1158\/0008-5472.CAN-08-2632","article-title":"CCCTC-binding factor confines the distal action of estrogen receptor","volume":"68","author":"Chan","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2023.154431_bib47","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2021.5228","article-title":"QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis","volume":"59","author":"Zhao","year":"2021","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.prp.2023.154431_bib48","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2006.06.7330","article-title":"Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers","volume":"24","author":"Griffith","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154431_bib49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1476-4598-9-117","article-title":"Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion","volume":"9","author":"Bauerle","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2023.154431_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172689","article-title":"RAC1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells","volume":"12","author":"Faria","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154431_bib51","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/ijc.24260","article-title":"R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK\/NF-kappaB pathway","volume":"124","author":"Festa","year":"2009","journal-title":"Int J. Cancer"},{"issue":"43","key":"10.1016\/j.prp.2023.154431_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1432-0436.1992.tb00667.x","article-title":"HP., Characterization of sciellin, a precursor to the cornified envelope of human keratinocytes","volume":"49","author":"Kvedar","year":"1992","journal-title":"Differentiation"},{"issue":"18","key":"10.1016\/j.prp.2023.154431_bib53","doi-asserted-by":"crossref","first-page":"25742","DOI":"10.18632\/oncotarget.8264","article-title":"Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis","volume":"7","author":"Chou CK","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154431_bib54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41419-020-03286-z","article-title":"Role of Sciellin in gallbladder cancer proliferation and formation of neutrophil extracellular traps","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"issue":"18","key":"10.1016\/j.prp.2023.154431_bib55","doi-asserted-by":"crossref","first-page":"25742","DOI":"10.18632\/oncotarget.8264","article-title":"Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis","volume":"7","author":"Chou CK","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154431_bib56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12885-020-6676-z","article-title":"Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate","volume":"20","author":"Wu","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2023.154431_bib57","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2265.2012.04465.x","article-title":"In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval","volume":"77","author":"Ulisse","year":"2012","journal-title":"Clin. Endocrinol. (Oxf. )"},{"key":"10.1016\/j.prp.2023.154431_bib58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3803\/EnM.2014.29.3.217","article-title":"Current status and future perspectives in differentiated thyroid cancer","volume":"29","author":"Kim","year":"2014","journal-title":"Endocrinol. Metab. (Seoul. )"},{"key":"10.1016\/j.prp.2023.154431_bib59","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1158\/1078-0432.CCR-09-1929","article-title":"Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms","volume":"16","author":"Culp","year":"2010","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.prp.2023.154431_bib60","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3892\/mmr.2017.6154","article-title":"Knockdown of the differentially expressed gene TNFRSF12A inhibits hepatocellular carcinoma cell proliferation and migration in vitro","volume":"15","author":"Wang","year":"2017","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.prp.2023.154431_bib61","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41419-019-1388-5","article-title":"NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K\/Akt\/NF-kappaB\/Snail axis and predicts outcome of the patients","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2023.154431_bib62","article-title":"Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2023.154431_bib63","first-page":"3634","article-title":"Aging-associated genes TNFRSF12A and CHI3L1 contribute to thyroid cancer: An evidence for the involvement of hypoxia as a driver","volume":"19","author":"Lian","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2023.154431_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259534","article-title":"Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway","volume":"16","author":"Arora","year":"2021","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.prp.2023.154431_bib65","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1158\/0008-5472.CAN-06-0418","article-title":"Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome","volume":"66","author":"Tran NL","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2023.154431_bib66","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fgene.2019.01299","article-title":"Association of TNFRSF12A Methylation With Prognosis in Hepatocellular Carcinoma With History of Alcohol Consumption","volume":"10","author":"Wang Y","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.prp.2023.154431_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172811","article-title":"Triptolide inhibits PDGF-induced proliferation of ASMCs through G0\/G1 cell cycle arrest and suppression of the AKT\/NF-kappaB\/cyclinD1 signaling pathway","volume":"867","author":"He","year":"2020","journal-title":"Eur. J. Pharm."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823001310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823001310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:00:48Z","timestamp":1759734048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823001310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":67,"alternative-id":["S0344033823001310"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154431","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance and diagnostic value of QPCT, SCEL and TNFRSF12A in papillary thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154431"}}